Recent status of primary sclerosing cholangitis in Japan

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 6, Issue 4, 1999, Pages 352-355

  Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Chronic pancreatitis; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGE DISTRIBUTION; ARTICLE; BILIARY TRACT TUMOR; BLOOD; CHOLELITHIASIS; ENTERITIS; EOSINOPHILIA; FEMALE; HUMAN; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PANCREATITIS; PREVALENCE; SCLEROSING CHOLANGITIS;

ADULT; AGE DISTRIBUTION; ANTIBODIES, ANTINUCLEAR; BILIARY TRACT NEOPLASMS; CHOLANGITIS, SCLEROSING; CHOLELITHIASIS; EOSINOPHILIA; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; JAPAN; MALE; MIDDLE AGED; PANCREATITIS; PREVALENCE;

EID: 0033253307     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050129     Document Type: Article

References (30)

1. Takikawa H, Manabe T (1997) Primary sclerosing cholangitis in Japan - analysis of 192 cases. J Gastroenterol 32:134-137
2. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL (1984) Current concept: primary sclerosing cholangitis. N Engl J Med 310:899-903
3. Wiesner RH, Porayko MK, LaRusso NF, Ludwig J (1993) Primary sclerosing cholangitis. In: Schiff L, Schiff ER (eds) Diseases of the liver, seventh edn. Lippincott, Philadelphia, pp 411-426
4. Ponsioen CIJ, Tytgat GNJ (1998) Primary sclerosing cholangitis: a clinical review. Am J Gastroenterol 93:515-523
5. Lazaridis KN, Wiesner RH, Porayko MK, Ludwig J, LaRusso NF (1999) Primary sclerosing cholangitis. In: Schiff ER, Sorrel MF, Maddrey WC (eds) Schiff's disease of the liver, eighth edn. Lippincott-Raven, Philadelphia, pp 649-699
6. Ludwig J, LaRusso NF, Wiesner RH (1986) Primary sclerosing cholangitis. Contemp Issues Surg Pathol 8:193-213
7. Lebovics E, Palmer M, Woo J, Schaffner F (1987) Outcome of primary sclerosing cholangitis. Analysis of long-term observation of 38 patients. Arch Intern Med 147:729-731
8. Helzberg JH, Petersen JM, Boyer JL (1987) Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 92:1869-1875
9. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10:430-436
10. Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH (1990) Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A stud of 66 subjects. Hepatology 11:7-11
11. Martin FM, Rossi RL, Nugent FW, Scholz FJ, Jenkins RL, Lewis WD, Gagner M, Foley E, Braasch JW (1990) Surgical aspects of sclerosing cholangitis. Results of 178 patients. Ann Surg 212:551-557
12. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R (1991) Natural history of prognostic variables in primary sclerosing cholangitis. Gastroenterology 100:1710-1717
13. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E (1994) Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 21:787-791
14. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F (1994) Risk factors in primary sclerosing cholangitis. J Hepatol 21:1061-1066
15. Lemmer ER, Bornman PC, Krige JEJ, Wright JP, Beningfield S, Jaskiewicz K, Kirsch RE, Kahn D, Terblanche JT, Robson SC (1994) Primary sclerosing cholangitis. Require for biliary drainage operation? Arch Surg 129:723-728
16. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G (1996) Natural history of prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38:610-615
17. Kochhar R, Goenka MK, Das K, Nagi B, Bhasin DK, Chawla YK, Vaiphei K, Singh K, Dilawari JB (1996) Primary sclerosing cholangitis: an experience from India. J Gastroenterol Hepatol 11:429-433
18. Helzberg JH, Petersen JM, Boyer JL (1987) Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features ad comparison of symptomatic and asymptomatic patients. Gastroenterology 92:1869-1875
19. Boberg KM, Fausa O, Haalang T, Holter E, Mellbye OJ, Spurklang A, Schrumpf E (1996) Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 23:1369-1376
20. Schimanski U, Stiehl A, Stremmel W, Theilmann L (1996) Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis. Endoscopy 28:346-349
21. Teare JP, Daly CA, Rodgers C, Padley SP, Coker RJ, Main J, Harris JR, Scullion D, Bray GP, Summerfield JA (1997) Pancreatic abnormalities and AIDS related sclerosing cholangitis. Genltourin Med 73:271-273
22. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L (1994) Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 20:57-64
23. Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, Theilmann L (1997) Efficacy of ursodeoxycholic acid treatment and endoscopic dilatation of major duct stenosis in primary sclerosing cholangitis. J Hepatol 26:560-566
24. De Maria N, Colantori A, Rosenbloom E, Van Thiel DH (1996) Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period. Hepatogastroenterology 43:1472-1479
25. Lindor KD (1997) Ursodiol for primary sclerosing cholangitis. N Engl J Med 336:691-695
26. van Milligen de Wit AW, Rauws EA, van Bracht J, Mulder CJ, Jones EA, Tytgat GN, Huibregtse K (1997) Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 46:344-347
27. Broome U, Eriksson LS (1994) Assessment of liver transplantation in patients with primary sclerosing cholangitis. J Hepatol 20:654-659
28. Ricci P, Therneau TM, Malinchoc M, Benson JT, Petz JL, Klintmalm GB, Crippin JS, Wiesner RH, Steers JL, Rakela J, Starzl TE, Dickson ER (1997) A prognostic model for the outcome of liver transplantation in patients with cholestatic liver diseases. Hepatology 25:672-677
29. Harrison RF, Davies MH, Neuberger JM, Hbscher SG (1994) Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis. Hepatology 20:356-361
30. Kita Y, Lake JR, Ferrell LD, Mori M, Roberts JP, Kakizoe S, Kiyosawa K, Tanaka E, Shiga J, Takikawa H, Inoue Y, Ohtake T, Ohtomo K, Yotsuyanagi H, Oka T, Harihara Y, Takayama T, Kubota K, Kawasaki H, Hashikura Y, Kawasaki S, Ascher NL, Makuuchi M (1998) Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case. Transplant Proc 30:3321-3323